Merufa JSC
UUPCOM:MRF23,000.00
VND
-3,000.00
(-11.54%)
ISIN
VN000000MRF2
Return %
Stock
S&P 500
1Y
-8.00
14.20
3Y
-43.90
81.12
5Y
-61.60
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Address
- IPO Date
- Dec 12, 2017
- Similar Companies
- Business
- Merufa Joint Stock Company is a Vietnam-based manufacturer and distributor of medical rubber products, healthcare consumables, and pharmaceutical packaging components. Established in 1987 in cooperation between the United Nations Population Fund (UNFPA) and the Government of Vietnam, and headquartered in Ho Chi Minh City, the company operates across the healthcare, medical device, and family planning sectors. The company specializes in the development, manufacture, and commercialization of a comprehensive portfolio of medical rubber, polymer, and latex products, comprising natural rubber condoms marketed under proprietary brands including Happy, OK, and Trust; sterile surgical gloves and non-sterile medical examination gloves; pharmaceutical-grade rubber stoppers, antibiotic vial caps, and injection closures; medical drainage tubes, catheters, and Penrose drains; plastic infusion bottles, intravenous tubing accessories, and medical connectors; water-based lubricating gels; and specialized processing machinery and equipment for medical rubber fabrication. Merufa distributes its products domestically to hospitals, public healthcare institutions, pharmacies, national family planning programs, and pharmaceutical manufacturers throughout Vietnam, while also supplying select medical rubber and disposable supplies to international export markets. In recent developments, Merufa has focused on optimizing its manufacturing operations at the Vinh Loc Industrial Park in Ho Chi Minh City to strengthen cost efficiencies and adapt to shifting supply-demand dynamics in the global medical consumables sector. The company maintains an annual production capacity of approximately 120 million condoms, 30 million pairs of medical gloves, and 40 million bottle closures, and has implemented operational improvements to enhance quality control under ISO standards. To navigate industry-wide margin pressures and market competition, Merufa has executed executive leadership reorganizations, including the transition of its General Director and the election of a renewed Board of Directors and Supervisory Board for the 2026–2031 term. Strategically, the company is rebalancing its commercial portfolio to prioritize high-demand hospital consumables, expanding direct supply agreements with public health procurement networks, and modernizing product lines to drive long-term revenue growth.